Product NDC: | 52686-221 |
Proprietary Name: | SHISEIDO Future |
Non Proprietary Name: | Ensulizole, Octinoxate and Octocrylene |
Active Ingredient(s): | 1.02; 2.5; 2.55 g/51g; g/51g; g/51g & nbsp; Ensulizole, Octinoxate and Octocrylene |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52686-221 |
Labeler Name: | SHISEIDO AMERICA INC. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20090901 |
Package NDC: | 52686-221-50 |
Package Description: | 1 JAR in 1 BOX (52686-221-50) > 51 g in 1 JAR |
NDC Code | 52686-221-50 |
Proprietary Name | SHISEIDO Future |
Package Description | 1 JAR in 1 BOX (52686-221-50) > 51 g in 1 JAR |
Product NDC | 52686-221 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Ensulizole, Octinoxate and Octocrylene |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20090901 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | SHISEIDO AMERICA INC. |
Substance Name | ENSULIZOLE; OCTINOXATE; OCTOCRYLENE |
Strength Number | 1.02; 2.5; 2.55 |
Strength Unit | g/51g; g/51g; g/51g |
Pharmaceutical Classes |